One explanation for this is the common belief of physicians that exogenous thyroid hormone (or its analogues) therapy in cardiac patients could precipitate development of arrhythmia, myocardial ischaemia/ infarction, or worsening of congestive heart failure. This evidence concerns the gene TG and cardiac arrhythmia.